Incyte’s Jakafi Flunks In Phase III Myelofibrosis Study As Loss Of Exclusivity Nears

 
• By Alaric DeArment
Incyte said 6 March that it would discontinue the Phase III LIMBER-304 study • Source: Shutterstock

More from Clinical Trials

More from R&D